Sun Pharmaceuticals Industries (BOM:524715) Debt-to-Asset : 0.00 (As of Dec. 2024)

Sun Pharmaceuticals Industries Debt-to-Asset Chart

Sun Pharmaceuticals Industries Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
Debt-to-Asset		Get a 7-Day Free Trial					0.12	0.06	0.02	0.09	0.04

Sun Pharmaceuticals Industries Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Asset	Get a 7-Day Free Trial															-	0.04	-	0.03	-

Competitive Comparison of Sun Pharmaceuticals Industries's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharmaceuticals Industries's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sun Pharmaceuticals Industries's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharmaceuticals Industries's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Sun Pharmaceuticals Industries's Debt-to-Asset falls into.

Sun Pharmaceuticals Industries Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Sun Pharmaceuticals Industries's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Sun Pharmaceuticals Industries's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharmaceuticals Industries  (BOM:524715) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Sun Pharmaceuticals Industries Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Sun Pharmaceuticals Industries's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharmaceuticals Industries Business Description